More Tianjin Lisheng Pharmaceutical Co., Ltd. news
Tianjin Lisheng Pharmaceutical Co., Ltd.SZSE: 002393

Tianjin Development Posts FY Results For Tianjin Lisheng Pharmaceutical

Mar 24, 2026 at 8:56 PM EDT · Issued by Tianjin Lisheng Pharmaceutical Co., Ltd.

On 6ix: 6ix.com/news/tianjin-development-posts-fy-results-for-tianjin-lisheng-pharmaceutical

Tianjin Development HKEX:882:

  • FY NET PROFIT ATTRIBUTABLE FOR TIANJIN LISHENG PHARMACEUTICAL RMB416.3 MILLION

  • FY TOTAL OPERATING INCOME FOR TIANJIN LISHENG PHARMACEUTICAL RMB1.39 BILLION

Tianjin Lisheng Pharmaceutical Co., Ltd. on 6ix

Story so far

  • Tianjin Development Posts FY Total Revenue From Ops For Tianjin Lisheng Pharmaceutical RMB1.39 BlnMar 10, 2026
  • Tianjin Development Posts FY Net Profit Attributable Guidance For Tianjin Lisheng PharmaceuticalJan 23, 2026

Earlier from Tianjin Lisheng Pharmaceutical

  • Tianjin Development Posts FY Total Revenue From Ops For Tianjin Lisheng Pharmaceutical RMB1.39 BlnMar 9
  • Tianjin Development Posts FY Net Profit Attributable Guidance For Tianjin Lisheng PharmaceuticalJan 23
  • Tianjin Development Says 9M Net Profit RMB374.3 Million For Tianjin Lisheng Pharmaceutical CoOct 23, 2025

Later from Tianjin Lisheng Pharmaceutical

  • Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 MlnApr 23
All Tianjin Lisheng Pharmaceutical news releases↗

Follow Tianjin Lisheng Pharmaceutical into a list and get an email when it puts out news.

Follow Tianjin Lisheng Pharmaceutical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer